升压素
升压素 用途与合成方法
Neurotensin Receptor
The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED 50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.
Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
升压素 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-04-30 | HY-P1255 | 升压素 | 103131-69-7 | 1mg | 918 |
2024-04-30 | HY-P1255 | 升压素 | 103131-69-7 | 5mg | 1830 |